• New growth formula

  The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy

  Prathamesh Mulye - November 04, 2019

• The Outperformers (51-60)

  These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

  September 03, 2019

• Cherry-Picking Fallen Angels — Part 2

  Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers

  Prathamesh Mulye - July 19, 2018

• Ajay Relan

  His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs

  Krishna Gopalan - September 18, 2017

• Self-healing

  Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China

  Krishna Gopalan - March 09, 2016